Barclays Maintains Equal-Weight on Adient, Raises Price Target to $27
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $25 to $27.
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $25 to $27.